Education
About Us
Working with TipRanks
Follow Us
Encision Inc (ECIA)
OTHER OTC:ECIA
ECIA Stock Chart & Stats
$0.14
$0.03(7.14%)
At close: 4:00 PM EST
$0.14
$0.03(7.14%)
Day’s Range― - ―
52-Week Range$0.09 - $0.49
Previous CloseN/A
Volume5.10K
Average Volume (3M)16.18K
Market Cap
$2.53M
Enterprise Value$3.33M
Total Cash (Recent Filing)$71.73K
Total Debt (Recent Filing)$1.53M
Price to Earnings (P/E)―
Beta0.31
Next Earnings
May 14, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding16,879,644
10 Day Avg. Volume10,380
30 Day Avg. Volume16,177
Financial Highlights & Ratios
PEG Ratio0.38
Price to Book (P/B)3.45
Price to Sales (P/S)0.87
P/FCF Ratio-42.25
Enterprise Value/Market Cap1.31
Enterprise Value/Revenue0.53
Enterprise Value/Gross Profit1.00
Enterprise Value/Ebitda-13.86
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
High Gross MarginA sustained ~53% gross margin indicates strong unit economics in its medical instruments business. This margin provides a durable buffer to absorb operating costs and supports eventual operating leverage if management curbs SG&A, aiding medium-term path to profitability.
Proven Cash Generation In Select YearsThe company has demonstrated it can generate positive operating and free cash flow in discrete years, showing the business model can be cash generative. That historic capability suggests management can restore cash conversion through cost control or volume recovery.
Lean Cost StructureA headcount of 22 implies a low fixed-cost base and potential agility. Lower structural payroll and overhead can extend runway, enable tighter expense control, and allow the company to scale selectively without large increases in fixed operating leverage.
Bears Say
TTM Negative EquityZero equity and negative total assets in the trailing-twelve-months materially weaken the financial cushion. Persistent negative net assets constrain borrowing, increase counterparty risk, and raise the likelihood of dilutive or punitive financing needs over the medium term.
Negative Operating/free Cash Flow TrendNegative OCF and FCF on a TTM basis indicate ongoing cash burn despite occasional positive years. Continued outflows pressure liquidity, force reliance on external capital, and limit the company's ability to invest in product development or commercial expansion sustainably.
Voluntary SEC DeregistrationFiling Form 15 to end SEC reporting reduces mandated transparency and may impair access to capital and investor liquidity. As a structural change, deregistration can increase cost of capital and reduce market participation, hurting long-term funding flexibility.
Encision News
ECIA FAQ
What was Encision Inc’s price range in the past 12 months?
Encision Inc lowest stock price was $0.09 and its highest was $0.49 in the past 12 months.
What is Encision Inc’s market cap?
Encision Inc’s market cap is $2.53M.
When is Encision Inc’s upcoming earnings report date?
Encision Inc’s upcoming earnings report date is May 14, 2026 which is in 70 days.
How were Encision Inc’s earnings last quarter?
Currently, no data Available
Is Encision Inc overvalued?
According to Wall Street analysts Encision Inc’s price is currently Overvalued.
Does Encision Inc pay dividends?
Encision Inc does not currently pay dividends.
What is Encision Inc’s EPS estimate?
Encision Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Encision Inc have?
Encision Inc has 16,879,644 shares outstanding.
What happened to Encision Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Encision Inc?
Currently, no hedge funds are holding shares in ECIA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Encision Inc
Encision Inc., a medical device company, designs, develops, manufactures, and markets patented surgical instruments in the United States. The company provides active electrode monitoring (AEM) surgical instruments and monitors that enhance patient safety and patient outcomes in laparoscopic surgical procedures. Its AEM instruments product line comprises a range of endo-mechanical instruments, including scissors, graspers, and dissectors, as well as fixed-tip electrodes and suction-irrigation electrodes. The company also offers various handles, which are used for advanced laparoscopic procedures that incorporate stiffer shafts and ergonomic features; and AEM EndoShield 2 burn protection systems, as well as markets AEM monitor product line that is used in conjunction with AEM instruments. The company sells its products through a network of direct and independent sales representatives. Encision Inc. was incorporated in 1991 and is based in Boulder, Colorado.
Technical Analysis
Ownership Overview
52.51% Insiders
6.29% Other Institutional Investors
41.20% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---